389 related articles for article (PubMed ID: 25263081)
41. A study of biomarkers in cervical carcinoma and clinical correlation of the novel biomarker MN.
Brewer CA; Liao SY; Wilczynski SP; Pastorekova S; Pastorek J; Zavada J; Kurosaki T; Manetta A; Berman ML; DiSaia PJ; Stanbridge EJ
Gynecol Oncol; 1996 Dec; 63(3):337-44. PubMed ID: 8946869
[TBL] [Abstract][Full Text] [Related]
42. Over-expression of wild-type p53-induced phosphatase 1 confers poor prognosis of patients with gliomas.
Liang C; Guo E; Lu S; Wang S; Kang C; Chang L; Liu L; Zhang G; Wu Z; Zhao Z; Ma S; Wang L; Jiao BH
Brain Res; 2012 Mar; 1444():65-75. PubMed ID: 22325093
[TBL] [Abstract][Full Text] [Related]
43. Expression and prognostic value of the WEE1 kinase in gliomas.
Music D; Dahlrot RH; Hermansen SK; Hjelmborg J; de Stricker K; Hansen S; Kristensen BW
J Neurooncol; 2016 Apr; 127(2):381-9. PubMed ID: 26738845
[TBL] [Abstract][Full Text] [Related]
44. Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients.
Lin L; Wang G; Ming J; Meng X; Han B; Sun B; Cai J; Jiang C
Tumour Biol; 2016 Nov; 37(11):15333-15339. PubMed ID: 27704357
[TBL] [Abstract][Full Text] [Related]
45. Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients.
Wang Q; Wang L; Li D; Deng J; Zhao Z; He S; Zhang Y; Tu Y
Cancer Epidemiol; 2013 Feb; 37(1):79-84. PubMed ID: 22999822
[TBL] [Abstract][Full Text] [Related]
46. Expression of far upstream element (FUSE) binding protein 1 in human glioma is correlated with c-Myc and cell proliferation.
Ding Z; Liu X; Liu Y; Zhang J; Huang X; Yang X; Yao L; Cui G; Wang D
Mol Carcinog; 2015 May; 54(5):405-15. PubMed ID: 24347226
[TBL] [Abstract][Full Text] [Related]
47. Transforming growth factor beta induced (TGFBI) is a potential signature gene for mesenchymal subtype high-grade glioma.
Pan YB; Zhang CH; Wang SQ; Ai PH; Chen K; Zhu L; Sun ZL; Feng DF
J Neurooncol; 2018 Apr; 137(2):395-407. PubMed ID: 29294230
[TBL] [Abstract][Full Text] [Related]
48. The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis.
Colpaert CG; Vermeulen PB; Fox SB; Harris AL; Dirix LY; Van Marck EA
Breast Cancer Res Treat; 2003 Sep; 81(2):137-47. PubMed ID: 14572156
[TBL] [Abstract][Full Text] [Related]
49. Prognostic significance of CDC25B expression in gliomas.
Nakabayashi H; Hara M; Shimizu K
J Clin Pathol; 2006 Jul; 59(7):725-8. PubMed ID: 16803948
[TBL] [Abstract][Full Text] [Related]
50. An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers.
Le QT; Chen E; Salim A; Cao H; Kong CS; Whyte R; Donington J; Cannon W; Wakelee H; Tibshirani R; Mitchell JD; Richardson D; O'Byrne KJ; Koong AC; Giaccia AJ
Clin Cancer Res; 2006 Mar; 12(5):1507-14. PubMed ID: 16533775
[TBL] [Abstract][Full Text] [Related]
51. PLEKHG5 is a novel prognostic biomarker in glioma patients.
Qian M; Chen Z; Wang S; Guo X; Zhang Z; Qiu W; Gao X; Xu J; Zhao R; Xue H; Li G
Int J Clin Oncol; 2019 Nov; 24(11):1350-1358. PubMed ID: 31309383
[TBL] [Abstract][Full Text] [Related]
52. Paxillin and carbonic anhydrase IX are prognostic markers in gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas.
Liu Z; Yang Z; Jiang S; Zou Q; Yuan Y; Li J; Li D; Liang L; Chen M; Chen S
Histopathology; 2014 Jun; 64(7):921-34. PubMed ID: 24354963
[TBL] [Abstract][Full Text] [Related]
53. Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas.
Ali-Osman F; Brunner JM; Kutluk TM; Hess K
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2253-61. PubMed ID: 9815622
[TBL] [Abstract][Full Text] [Related]
54. Expression of carbonic anhydrase 9 at the invasion front of gastric cancers.
Chen J; Röcken C; Hoffmann J; Krüger S; Lendeckel U; Rocco A; Pastorekova S; Malfertheiner P; Ebert MP
Gut; 2005 Jul; 54(7):920-7. PubMed ID: 15951534
[TBL] [Abstract][Full Text] [Related]
55. Slit2 and Robo1 expression as biomarkers for assessing prognosis in brain glioma patients.
Liu L; Li W; Geng S; Fang Y; Sun Z; Hu H; Liang Z; Yan Z
Surg Oncol; 2016 Dec; 25(4):405-410. PubMed ID: 27916173
[TBL] [Abstract][Full Text] [Related]
56. IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.
Leeper HE; Caron AA; Decker PA; Jenkins RB; Lachance DH; Giannini C
Oncotarget; 2015 Oct; 6(30):30295-305. PubMed ID: 26210286
[TBL] [Abstract][Full Text] [Related]
57. Upregulation of miR-183 expression and its clinical significance in human brain glioma.
Ye Z; Zhang Z; Wu L; Liu C; Chen Q; Liu J; Wang X; Zhuang Z; Li W; Xu S; Hang C
Neurol Sci; 2016 Aug; 37(8):1341-7. PubMed ID: 27215622
[TBL] [Abstract][Full Text] [Related]
58. IL-10 and PRKDC polymorphisms are associated with glioma patient survival.
Hu M; Du J; Cui L; Huang T; Guo X; Zhao Y; Ma X; Jin T; Li G; Song J
Oncotarget; 2016 Dec; 7(49):80680-80687. PubMed ID: 27811370
[TBL] [Abstract][Full Text] [Related]
59. Longitudinal expression analysis of αv integrins in human gliomas reveals upregulation of integrin αvβ3 as a negative prognostic factor.
Schittenhelm J; Schwab EI; Sperveslage J; Tatagiba M; Meyermann R; Fend F; Goodman SL; Sipos B
J Neuropathol Exp Neurol; 2013 Mar; 72(3):194-210. PubMed ID: 23399898
[TBL] [Abstract][Full Text] [Related]
60. The correlation of bone morphogenetic protein 2 with poor prognosis in glioma patients.
Yang X; Li D; Cheng S; Fan K; Sheng L; Zhang J; Feng B; Xu Z
Tumour Biol; 2014 Nov; 35(11):11091-5. PubMed ID: 25099618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
